Polaris Market Research

Cardiac Rhythm Management (CRM) Devices Market Size Projected to Influence USD 33bn in 2026 - Boston Scientific Corporation, Medtronic, Abbott Laboratories, LivaNova PLC

Cardiac Rhythm Management Devices Market is anticipated to grow at a CAGR of 7.6% during the forecast period and is estimated to reach USD 33.0 billion by 2026 from USD 17.2 billion in 2017.

 

New York, NY -- (SBWIRE) -- 11/14/2018 -- High cholesterol level, high alcohol consumption, smoking and obesity causes heart diseases. Due to these reasons, approximately 30% of total deaths are caused by cardiovascular diseases across the world. Cardiac Rhythm Management (CRM) is a procedure of monitoring the heart function through a device. This device is used to deliver therapeutic solutions to people suffering from cardiac disorders such as cardiac arrests, heart failure, or cardiac arrhythmias. Cardiac ailments are the primary reasons causing irregular heartbeat.

Request Sample for more Professional and Technical insights @
https://www.polarismarketresearch.com/industry-analysis/cardiac-rhythm-management-devices-market/request-for-free-sample

Increasing patient awareness is considered to be one of the reasons generating lucrative market opportunity for the Cardiac Rhythm Management (CRM) Devices Market. The influence of this factor has affected the market growth significantly in emerging countries, as the usage and the adoption rate for these devices is very low in emerging regions. Currently, there are number of implantable-assisted and novel products available however, the patients and surgeons present in developing economies are unaware about the advancement of CRM devices, thereby restricting the market growth. In addition, high prevalence of cardiovascular diseases, technological advancements, rising government initiatives and increasing rise in life expectancy are other factors anticipated to boost the market.

Some of the leading companies profiled in the Cardiac Rhythm Management (CRM) Devices Market report include: -

- Abiomed Inc.
- Berlin Heart GmbH
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardiac Science Corporation
- General Electric Company (GE)
- Hill-Rom Holdings Inc.
- Koninklijke Philips N.V.
- LivaNova PLC
- Medtronic plc
- SCHILLER AG
- Abbott Laboratories

For 'Queries' related to this research report, Make an Enquiry @
https://www.polarismarketresearch.com/industry-analysis/cardiac-rhythm-management-devices-market/inquire-before-buying

Cardiac Rhythm Management (CRM) Devices Market report provides an extensive qualitative and quantitative analysis of the market trends and growth prospects of the market. This report also comprises a detailed geographic analysis of the market across North America, Europe, APAC, Latin America, and MEA regions. North America is further segmented into U.S., Canada, and Mexico. European regional analysis section covers Germany, UK, Italy, and France. While the Asia Pacific region is bifurcated into China, India, and Japan. In 2017, North America market was estimated to dominate the market growth due to developed healthcare infrastructure, favourable reimbursement schemes, higher healthcare expenditure, and increasing awareness among the population.

TOC of Cardiac Rhythm Management (CRM) Devices Market:

Chapter 1. Overview and Scope
Chapter 2. Market Summary
Chapter 3 Cardiac Rhythm Management (CRM) Devices Market Size and Forecast
Chapter 4. Dynamics and Segmentation
Chapter 5. Detailed Insight on Key Company
Chapter 6. Research Methodology and Reference
Chapter 7. Competitive Landscape
TOC Continued…...!!!!!